Literature DB >> 19528962

Targeting angiogenesis to restore the microcirculation after reperfused MI.

Anja M van der Laan1, Jan J Piek, Niels van Royen.   

Abstract

Since early reperfusion therapy for patients with acute myocardial infarction (AMI) was demonstrated to decrease mortality, numerous improvements in AMI management have focused on prompt reperfusion of the epicardial coronary arteries. However, in a substantial group of patients with AMI, reperfusion of the myocardial tissue is hindered by dysfunction of the microvasculature, despite successful restoration of the epicardial coronary flow. These patients have prolonged ischemia and an adverse clinical outcome. Although several studies investigating the etiology of microvascular dysfunction have been performed, little is known about the restoration process of microvascular dysfunction after reperfused AMI. The objective of this Review is to summarize our knowledge on natural restoration of the microvasculature after reperfused AMI, particularly with regard to angiogenesis, discuss diagnostic modalities used to identify patients with microvascular dysfunction and highlight the potential of pharmacological and cellular interventions to stimulate the recovery of the microvasculature by promoting angiogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19528962     DOI: 10.1038/nrcardio.2009.103

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  92 in total

1.  Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis?

Authors:  P Carmeliet
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

Review 2.  Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease.

Authors:  N van Royen; J J Piek; I Buschmann; I Hoefer; M Voskuil; W Schaper
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

3.  Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance.

Authors:  A Kranz; C Rau; M Kochs; J Waltenberger
Journal:  J Mol Cell Cardiol       Date:  2000-01       Impact factor: 5.000

Review 4.  Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis.

Authors:  Yuichi Oike; Kunio Yasunaga; Toshio Suda
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

5.  Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.

Authors:  Willibald Maier; Lukas A Altwegg; Roberto Corti; Steffen Gay; Martin Hersberger; Friedrich E Maly; Gabor Sütsch; Marco Roffi; Michel Neidhart; Franz R Eberli; Felix C Tanner; Sharon Gobbi; Arnold von Eckardstein; Thomas F Lüscher
Journal:  Circulation       Date:  2005-03-07       Impact factor: 29.690

Review 6.  Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.

Authors:  Seppo Ylä-Herttuala; Johanna E Markkanen; Tuomas T Rissanen
Journal:  Trends Cardiovasc Med       Date:  2004-11       Impact factor: 6.677

7.  In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions.

Authors:  Xue-Hai Chen; Shinya Minatoguchi; Kenichiro Kosai; Kentaro Yuge; Tomoyuki Takahashi; Masazumi Arai; Ningyuan Wang; Yu Misao; Chuanjiang Lu; Hirohito Onogi; Hiroyuki Kobayashi; Shinji Yasuda; Masayasu Ezaki; Hiroaki Ushikoshi; Genzou Takemura; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  J Card Fail       Date:  2007-12       Impact factor: 5.712

Review 8.  Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

Authors:  Vijayalakshmi Kunadian; Cafer Zorkun; Scott P Williams; Leah H Biller; Alexandra M Palmer; Katherine J Ogando; Michelle E Lew; Navin Nethala; William J Gibson; Susan J Marble; Jacqueline L Buros; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-09-26       Impact factor: 2.300

9.  Chimerism of the transplanted heart.

Authors:  Federico Quaini; Konrad Urbanek; Antonio P Beltrami; Nicoletta Finato; Carlo A Beltrami; Bernardo Nadal-Ginard; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

10.  Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart.

Authors:  Munira Xaymardan; Jingang Zheng; Inga Duignan; Andrew Chin; Jacquelyne M Holm; Victoria L T Ballard; Jay M Edelberg
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

View more
  46 in total

1.  PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.

Authors:  Haokao Gao; Lixin Lang; Ning Guo; Feng Cao; Qimeng Quan; Shuo Hu; Dale O Kiesewetter; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-25       Impact factor: 9.236

2.  Clonal and diverse: revisiting cardiac endothelial cells after myocardial infarction.

Authors:  David Rohde; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2019-08-07       Impact factor: 29.983

3.  A bouquet for a broken heart: can flowers repair a damaged heart?

Authors:  Charles K Thodeti
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

4.  Injectable Drug-Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction.

Authors:  Jun Fang; Jaekyung Koh; Qizhi Fang; Huiliang Qiu; Maani M Archang; Mohammad Mahdi Hasani-Sadrabadi; Hiromi Miwa; Xintong Zhong; Richard Sievers; Dong-Wei Gao; Randall Lee; Dino Di Carlo; Song Li
Journal:  Adv Funct Mater       Date:  2020-09-06       Impact factor: 18.808

5.  Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction.

Authors:  Ignacio M Seropian; Juan P Cerliani; Stefano Toldo; Benjamín W Van Tassell; Juan M Ilarregui; Germán E González; Mirian Matoso; Fadi N Salloum; Ryan Melchior; Ricardo J Gelpi; Juan C Stupirski; Alejandro Benatar; Karina A Gómez; Celina Morales; Antonio Abbate; Gabriel A Rabinovich
Journal:  Am J Pathol       Date:  2012-11-09       Impact factor: 4.307

Review 6.  Protein therapeutics for cardiac regeneration after myocardial infarction.

Authors:  Vincent F M Segers; Richard T Lee
Journal:  J Cardiovasc Transl Res       Date:  2010-07-07       Impact factor: 4.132

7.  An association between gene expression and better survival in female mice following myocardial infarction.

Authors:  Quanhai Chen; Roy Williams; Chastity L Healy; Casey D Wright; Steven C Wu; Timothy D O'Connell
Journal:  J Mol Cell Cardiol       Date:  2010-08-06       Impact factor: 5.000

Review 8.  Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis.

Authors:  Longhou Fang; Chao Liu; Yury I Miller
Journal:  Transl Res       Date:  2013-10-02       Impact factor: 7.012

9.  The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study.

Authors:  Sultan Pehlivan; Murat Serdar Gurses; Mustafa Numan Ural; Sumeyya Akyol; Filiz Eren; Nursel Turkmen Inanir; Mehmet Akif Gulec; Bulent Eren; Recep Fedakar; Kadir Demircan; Omer Akyol
Journal:  Lab Med       Date:  2016-06-26

10.  Evaluation of inflammatory response to acute ischemia using near-infrared fluorescent reactive oxygen sensors.

Authors:  Selena Magalotti; Tiffany P Gustafson; Qian Cao; Dana R Abendschein; Richard A Pierce; Mikhail Y Berezin; Walter J Akers
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.